tradingkey.logo
tradingkey.logo
Search

Molecular Partners AG

MOLN
Add to Watchlist
4.020USD
+0.050+1.26%
Close 07-23 16:00ETQuotes delayed by 15 min
150.79MMarket Cap
LossP/E TTM

MOLN Financials

See Molecular Partners AG's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Molecular Partners AG Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.44/-0.42
Revenue / Forecast
0.00/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
-100.00%
EPS(YoY)
-2.09
-19.27%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023H2
FY2023Q2
FY2023H1
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022H2
FY2022H1
FY2022Q1
FY2021Q4
FY2021Q3
FY2021H2
Financial Indicators
EPS
---0.44
-26.10%-0.42
28.47%-0.41
----
53.08%-0.34
-52.20%-0.58
5.89%-0.51
23.52%-0.38
-23.49%-0.72
8.30%-0.38
----
-273.32%-0.54
----
---0.49
---0.58
---0.42
---0.15
----
----
----
----
----
----
Revenue
--0.00
--0.00
-100.00%0.00
----
-100.00%0.00
-73.03%762.60K
292.83%1.84M
-9.65%3.01M
-59.59%1.17M
19.15%2.83M
-25.46%4.04M
-96.08%469.19K
-97.92%3.92M
-98.06%3.33M
50.79%2.89M
-38.76%2.37M
--11.97M
-4.34%5.43M
3803.96%187.92M
--172.28M
--1.92M
----
----
Net Profit
---16.81M
-25.74%-15.99M
19.88%-14.72M
----
43.21%-12.71M
-44.30%-18.37M
0.84%-17.92M
22.87%-12.46M
-19.79%-22.39M
4.82%-12.73M
-7.16%-35.34M
-292.51%-18.07M
-122.98%-34.78M
-110.58%-16.15M
1.80%-18.69M
0.94%-13.37M
---4.60M
-2.68%-32.97M
513.68%151.33M
--152.68M
---19.03M
----
----
Net Margin
----
----
----
----
----
-435.08%-2408.81%
74.76%-972.40%
14.63%-413.62%
-196.46%-1916.67%
20.12%-450.18%
----
-9915.78%-3852.29%
----
---484.52%
---646.51%
---563.54%
---38.46%
----
----
----
----
----
----
Gross Margin
----
----
----
----
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
----
0.00%100.00%
----
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
Debt to assets ratio
--3.81%
131.49%3.57%
-23.31%1.37%
-17.27%1.48%
-16.27%1.54%
-1.69%1.78%
-3.13%1.79%
--1.81%
-0.44%1.84%
-1.04%1.81%
----
1.40%1.84%
----
----
--1.85%
--1.83%
--1.82%
----
----
----
----
----
----
Revenue
--0.00
--0.00
-100.00%0.00
----
-100.00%0.00
-73.03%762.60K
292.83%1.84M
-9.65%3.01M
-59.59%1.17M
19.15%2.83M
-25.46%4.04M
-96.08%469.19K
-97.92%3.92M
-98.06%3.33M
50.79%2.89M
-38.76%2.37M
--11.97M
-4.34%5.43M
3803.96%187.92M
--172.28M
--1.92M
----
----
Operating profit
---17.20M
4.41%-16.01M
9.20%-14.83M
----
11.13%-16.75M
-8.83%-16.34M
-5.73%-18.99M
-5.79%-17.45M
-17.51%-18.84M
-1.77%-15.01M
-7.30%-34.11M
-180.17%-17.96M
-123.51%-35.02M
-110.84%-16.49M
4.42%-16.04M
-4.75%-14.75M
---6.41M
-4.50%-31.79M
492.80%148.94M
--152.11M
---16.78M
----
----
Net Profit
---16.81M
-25.74%-15.99M
19.88%-14.72M
----
43.21%-12.71M
-44.30%-18.37M
0.84%-17.92M
22.87%-12.46M
-19.79%-22.39M
4.82%-12.73M
-7.16%-35.34M
-292.51%-18.07M
-122.98%-34.78M
-110.58%-16.15M
1.80%-18.69M
0.94%-13.37M
---4.60M
-2.68%-32.97M
513.68%151.33M
--152.68M
---19.03M
----
----
Current assets
--106.09M
-29.89%122.44M
-19.09%135.49M
-23.70%150.15M
-19.83%174.64M
-29.00%167.45M
-22.24%196.80M
--198.25M
-20.25%217.84M
-14.16%235.85M
-20.25%217.84M
-14.74%253.09M
-14.74%253.09M
----
56.55%273.16M
49.42%274.76M
--296.83M
56.55%273.16M
37.51%296.83M
--302.73M
--174.49M
----
----
Total current liabilities
--11.26M
14.16%13.94M
24.95%14.60M
18.97%16.06M
-25.18%12.21M
-27.78%11.69M
-23.80%13.50M
--13.51M
-11.79%16.32M
-15.38%16.18M
-11.79%16.32M
-25.38%17.72M
-25.38%17.72M
----
-62.86%18.50M
-56.07%19.12M
--23.74M
-62.86%18.50M
-62.19%23.74M
--30.34M
--49.80M
----
----
Total assets
--112.14M
-28.08%129.05M
-19.24%139.46M
-23.68%154.73M
-20.07%179.45M
-28.86%172.69M
-22.19%202.75M
--204.21M
-20.16%224.51M
-14.01%242.73M
-20.16%224.51M
-14.50%260.59M
-14.50%260.59M
----
53.25%281.21M
45.91%282.26M
--304.78M
53.25%281.21M
35.11%304.78M
--310.94M
--183.49M
----
----
Total liabilities
--24.57M
43.92%27.52M
19.59%20.67M
22.50%21.91M
-22.94%19.12M
-29.12%17.28M
-35.48%17.88M
--18.77M
-14.58%24.81M
-18.31%24.38M
-14.58%24.81M
-18.56%27.72M
-18.56%27.72M
----
-58.19%29.05M
-47.61%29.85M
--34.03M
-58.19%29.05M
-56.84%34.03M
--47.21M
--69.48M
----
----
Total equity
--87.57M
-36.67%101.53M
-23.56%118.79M
-28.15%132.83M
-19.71%160.33M
-28.83%155.41M
-20.61%184.87M
--185.44M
-20.81%199.69M
-13.50%218.35M
-20.81%199.69M
-13.99%232.87M
-13.99%232.87M
----
121.16%252.16M
84.95%252.42M
--270.75M
121.16%252.16M
84.52%270.75M
--263.73M
--114.02M
----
----
Net operating income
---18.11M
2.03%-13.61M
15.20%-11.80M
----
17.41%-13.90M
-4.27%-13.91M
---17.26M
---17.37M
-12.35%-16.83M
26.24%-13.34M
11.37%-30.40M
----
-120.82%-32.02M
----
26.96%-14.98M
13.48%-18.09M
---12.80M
15.86%-34.30M
368.70%153.81M
--163.14M
---20.50M
---20.91M
-3541.64%-40.76M
Net investment
---5.14M
338.67%14.62M
-15.01%12.72M
----
-129.52%-6.13M
-18.87%14.96M
--14.20M
--17.99M
-45.64%20.75M
166.66%18.44M
357.95%39.51M
----
105.98%6.67M
----
260.73%38.18M
-4.80%-27.67M
---16.34M
157.55%8.63M
-1149.78%-111.67M
---93.34M
--10.58M
---26.40M
42.30%-14.99M
Net financing
---373.54K
-102.19%-379.17K
-12.15%-378.02K
----
5235.14%17.32M
-1.64%-337.07K
---317.29K
---330.07K
-5.56%-337.29K
64.21%-331.63K
48.47%-674.59K
----
-81.65%-645.56K
----
-33.64%-319.54K
29.95%-926.61K
---284.11K
13.91%-1.31M
-100.63%-355.40K
---69.80K
---239.11K
---1.32M
-101.21%-1.52M

FAQs

What are the current assets of Molecular Partners AG?

According to Molecular Partners AG's FY2025 earnings report, its current assets were 122.44M, with a year-on-year change of -29.89.

What are the total assets of Molecular Partners AG?

According to Molecular Partners AG's FY2025 earnings report, its total assets of Molecular Partners AG were 129.05M, with a year-on-year change of -28.08.

What are the total liabilities of Molecular Partners AG?

According to Molecular Partners AG's FY2025 earnings report, its total liabilities of Molecular Partners AG were 27.52M, with a year-on-year change of 43.92.

What is the total equity of Molecular Partners AG?

According to Molecular Partners AG's FY2025 earnings report, its total equity of Molecular Partners AG was 101.53M, with a year-on-year change of -36.67.

What is the net operating income of Molecular Partners AG?

According to Molecular Partners AG's FY2025 earnings report, its net operating income of Molecular Partners AG was -70.06M, with a year-on-year change of -1.11.

What is the net investment of Molecular Partners AG?

According to Molecular Partners AG's FY2025 earnings report, its net investment of Molecular Partners AG was 89.51M, with a year-on-year change of 118.16.

What is the net financing of Molecular Partners AG?

According to Molecular Partners AG's FY2025 earnings report, its net financing of Molecular Partners AG was -1.45M, with a year-on-year change of -108.89.

What is the Earnings Per Share (EPS) of Molecular Partners AG?

According to Molecular Partners AG's FY2025 earnings report, its Earnings Per Share (EPS) was -2.09, with a year-on-year change of -19.27.

What is the net income of Molecular Partners AG?

According to Molecular Partners AG's FY2025 earnings report, its net income was -77.92M, with a year-on-year change of -27.37.

What is the debt-to-asset ratio of Molecular Partners AG?

According to Molecular Partners AG's FY2025 earnings report, its debt-to-asset ratio was 3.57, with a year-on-year change of 131.49.

What is the Return on Equity (ROE) of Molecular Partners AG?

According to Molecular Partners AG's FY2025 earnings report, its Return on Equity (ROE) was -55.55, with a year-on-year change of -63.46.

What is the Return on Assets (ROA) of Molecular Partners AG?

According to Molecular Partners AG's FY2025 earnings report, its Return on Assets (ROA) was -47.31, with a year-on-year change of -56.20.

What is the operating profit of Molecular Partners AG?

According to Molecular Partners AG's FY2025 earnings report, its operating profit was -70.06M, with a year-on-year change of -1.11.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.